Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Willemen

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Acta Cardiologica|November 3, 2022
Trends and outcomes in transcatheter aortic valve implantation in Belgium: a 13-year single centre experienceAndrea Bezzeccheri, Paul Vermeersch, Stefan Verheye, et al.
Structural Heart : the Journal of the Heart Team|December 1, 2025
Managing Hostile Aortic Anatomies Using an Extended-Length Introducer Sheath During Transfemoral Transcatheter Aortic Valve Replacement: Rationale and Clinical OutcomesYusuke Kobari, Davorka Lulic, Arif A Khokhar, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer ImmunotherapyEvelien L J M Smits, Barbara Stein, Griet Nijs, et al.
Minerva Cardiology and Angiology|February 25, 2022
Feasibility, safety and predictors of a successful "blind wiring" antegrade approach in the percutaneous treatment of chronic coronary total occlusionsGiovanni M Vescovo, Pavel Somov, Carlo Zivelonghi, et al.
Human Vaccines & Immunotherapeutics|June 20, 2013
Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapySébastien Anguille, Eva Lion, Johan Van den Bergh, et al.
Journal of Hematology & Oncology|October 1, 2016
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cellsHeleen H Van Acker, Sébastien Anguille, Yannick Willemen, et al.
Oncotarget|December 18, 2015
Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activityJohan Van den Bergh, Yannick Willemen, Eva Lion, et al.
Plos One|May 8, 2015
Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent MannerSébastien Anguille, Heleen H Van Acker, Johan Van den Bergh, et al.
American Heart Journal|October 7, 2024
Prospective study on the impact of different antithrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter aortic valves-The NOTION-4 trialJani Thuraiaiyah, Troels Højsgaard Jørgensen, Jesper Møller Jensen, et al.
STAR Protocols|February 28, 2023
In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cellsSanne van der Heijden, Donovan Flumens, Maarten Versteven, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Acta Cardiologica|November 3, 2022
Trends and outcomes in transcatheter aortic valve implantation in Belgium: a 13-year single centre experienceAndrea Bezzeccheri, Paul Vermeersch, Stefan Verheye, et al.
Structural Heart : the Journal of the Heart Team|December 1, 2025
Managing Hostile Aortic Anatomies Using an Extended-Length Introducer Sheath During Transfemoral Transcatheter Aortic Valve Replacement: Rationale and Clinical OutcomesYusuke Kobari, Davorka Lulic, Arif A Khokhar, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer ImmunotherapyEvelien L J M Smits, Barbara Stein, Griet Nijs, et al.
Minerva Cardiology and Angiology|February 25, 2022
Feasibility, safety and predictors of a successful "blind wiring" antegrade approach in the percutaneous treatment of chronic coronary total occlusionsGiovanni M Vescovo, Pavel Somov, Carlo Zivelonghi, et al.
Human Vaccines & Immunotherapeutics|June 20, 2013
Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapySébastien Anguille, Eva Lion, Johan Van den Bergh, et al.
Journal of Hematology & Oncology|October 1, 2016
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cellsHeleen H Van Acker, Sébastien Anguille, Yannick Willemen, et al.
Oncotarget|December 18, 2015
Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activityJohan Van den Bergh, Yannick Willemen, Eva Lion, et al.
Plos One|May 8, 2015
Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent MannerSébastien Anguille, Heleen H Van Acker, Johan Van den Bergh, et al.
American Heart Journal|October 7, 2024
Prospective study on the impact of different antithrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter aortic valves-The NOTION-4 trialJani Thuraiaiyah, Troels Højsgaard Jørgensen, Jesper Møller Jensen, et al.
STAR Protocols|February 28, 2023
In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cellsSanne van der Heijden, Donovan Flumens, Maarten Versteven, et al.
Pageof 4